Clinical Trials Logo

Placebo Effect clinical trials

View clinical trials related to Placebo Effect.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05004467 Completed - Disability Physical Clinical Trials

Clinical Predictive Effects of Mulligan Treatment in Patients With Chronic Neck Pain

Start date: August 2, 2021
Phase: N/A
Study type: Interventional

The aim of the study is the measurement and comparison of two manual therapy techniques, the Mulligan´s mobilization with movement technique, and de placebo technique, both applicated in patients with subacute neck pain.

NCT ID: NCT04571827 Completed - Disability Clinical Trials

The Influence of Expectations on Post-needling Soreness and Pain Processing After Dry Needling Treatment

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The general objective of the study is to determine the effectiveness on local mechanical hypoalgesia, pain intensity, disability and psychological variables of the deep dry needling technique on a latent trigger point of the upper trapezius muscle. The specific objective of the study is to observe the interaction between patient expectations and hypoalgesic effects in patients who will receive the same technique but with different explanations about it before punction and which could influence on the modulation of post-punction pain.

NCT ID: NCT03694886 Completed - Placebo Effect Clinical Trials

The Effect of Tablet Size on Cognitive Performance Caffeine

CaC
Start date: October 31, 2018
Phase: Phase 4
Study type: Interventional

This study aims to assess if tablet size, due to placebo effect, alters participants' performance on cognitive tests after consuming caffeine. Participants will be randomly assigned to one of four groups: 1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule.

NCT ID: NCT03017534 Completed - Clinical trials for Musculoskeletal Manipulations

Non-Specific Effects of Manual Therapy

Start date: January 2017
Phase: N/A
Study type: Interventional

The mechanism responsible for improvement following manual physical therapy techniques is unknown. Previous studies have indicated both biomechanical and neurophysiologic effects which may be responsible for clinical changes observed. Yet, other studies report clinical changes following sham interventions. Through a mixed-methods design, this study aims to gain more understanding of the social and contextual factors that may be related to the improvement often observed following manual therapy techniques.

NCT ID: NCT02802241 Completed - Clinical trials for Irritable Bowel Syndrome

Effects of Open-label vs Double-blind Treatment in IBS

Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.

NCT ID: NCT02578420 Completed - Pain Clinical Trials

Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo

Start date: January 2016
Phase: N/A
Study type: Interventional

To date, very little is known about the mechanisms of open-label placebo treatment and there is a lack in highly controlled experimental designs. Therefore, the planned project will test well-established explanatory models of (deceptive) placebo, i.e., (1) expectancy, (2) meaning response, in an open-label placebo design, investigating their influence on placebo analgesia.

NCT ID: NCT02578212 Completed - Pain Clinical Trials

Trust Game and Placebo Response

Start date: January 2015
Phase: N/A
Study type: Interventional

In the proposed study, investigators aim to investigate the role of interpersonal trust in the conditioned placebo analgesia process with healthy male subjects in a standardized experimental heat pain paradigm.

NCT ID: NCT02365220 Completed - Stress Clinical Trials

Smartphone Application, Mood and Stress

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the placebo effect in a smartphone-based training, ostensibly designed to improve mood and perceived stress by daily exposition to either mock sound or color.

NCT ID: NCT01501747 Completed - Pharmacokinetics Clinical Trials

The Placebo Effect May Involve Modulating Drug Bioavailability

Start date: February 2012
Phase: N/A
Study type: Interventional

The total effect of a medication is the sum of its drug effect, placebo effect (meaning response of placebo), and their interaction. Current interpretation of clinical trials (the gold standard of evidence-based-medicine) assumes no interaction, and the mechanism(s) underlying such interaction have not been fully explored. One possibility is that the placebo effect may modulate drug bioavailability. Using caffeine as a model drug, we have recently shown that the placebo effect of caffeine ingestion prolongs caffeine half life. Due to the novelty of this finding and its important clinical practice and clinical research implications, it needs to be confirmed in another set of subjects and extended to additional drugs. The results of the study are expected to further our understanding of the mechanism of action of a widely used medical intervention, i.e., placebo. The results will be important for both clinical practice and clinical research.

NCT ID: NCT01501591 Completed - Placebo Effect Clinical Trials

Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size

Start date: November 2012
Phase: N/A
Study type: Interventional

The total effect of a medication is the sum of its drug effect, placebo effect (meaning response of placebo), and their possible interaction. Current interpretation of the results of clinical trials (the gold standard in evidence based medicine) assumes no such interaction. Using a novel cross-over balanced placebo design and caffeine as a model drug, the investigators have recently shown that a negative interaction does exist; suggesting that the size of drug effect as currently measured by clinical trials may not be accurate. Due to the novelty of the findings and their important clinical practice and research implications, they need to be confirmed using another drug; and the size of drug effect measured using the novel design need to be directly compared to that measured using conventional clinical trial design. The results of the study are expected to further our understanding of a widely used medical intervention, i.e., placebo, and help assess the appropriateness of randomized clinical trials in determining the size of drug effect.